Okegawa, Japan

Hideo Kikkawa


Average Co-Inventor Count = 5.0

ph-index = 2

Forward Citations = 8(Granted Patents)


Company Filing History:


Years Active: 1994-1999

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations in Pharmaceutical Chemistry: The Work of Hideo Kikkawa

Introduction: Hideo Kikkawa is an accomplished inventor based in Okegawa, Japan. With a total of two patents to his name, Kikkawa has made significant contributions to the field of pharmaceutical chemistry, particularly focusing on compounds that demonstrate therapeutic activity in treating respiratory conditions such as asthma.

Latest Patents: Kikkawa's latest patents include a pyridine derivative that exhibits excellent bronchoconstriction inhibitory activity and anti-inflammatory effects on the airway. The chemical formulation (I), containing specific groups such as hydroxymethyl and lower alkyl, demonstrates potential for use in the prophylaxis and treatment of asthma. Additionally, Kikkawa has developed naphthalene derivatives that possess bronchodilating capabilities, making them valuable in managing asthma-related conditions.

Career Highlights: Hideo Kikkawa is affiliated with Tanabe Seiyaku Company, Limited, where he continues to advance his research in pharmaceuticals. His innovative work in drug development has paved the way for new therapeutic options in managing respiratory diseases.

Collaborations: Throughout his career, Kikkawa has collaborated with notable colleagues such as Katsuo Ikezawa and Tatsuzo Ukita. These partnerships have fostered a creative research environment, facilitating the sharing of ideas and expertise in the design of novel compounds.

Conclusion: Hideo Kikkawa's work in the development of new pharmaceutical compounds showcases the impact of dedicated inventors in the health sciences. His patents reflect a commitment to improving therapeutic approaches for asthma, potentially benefiting countless patients worldwide.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…